© Christian Mueller, 2012 - 2020 │  Disclaimer  │  Imprint  │  Webmaster │ Last Update: July 2020
Background:  The GALACTIC TRIAL (Goal Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study) is a  prospective, randomized, interventional controlled trial. Designed to determine whether an early goal-directed decrement  of preload and afterload with a target systolic blood pressure of 90-110 mmHg by aggressive vasodilatation in patients  with acute HF in the non-ICU setting is safe, and leads to a better clinical and economical outcome. Trial Registration No: NCT00512759 (clinicaltrials.gov)   Link  Trial Status: finished, results submitted  Enrolling Centers: Switzerland Worldwide: University Hospital Basel Brazil: University of Sao Paulo Cantonal Hospital Aarau (Enrollment finished) Spain: Hospital de la Santa Creu i Sant Pau Cantonal Hospital Luzern (Enrollment finished) Hospital Germans Trias i Pujo Hospital St. Gallen Germany: Klinikum Nürnberg Nord (Enrollm. finished) Klinikum Mainz Bulgaria: Sofia, University Hospital Tsaritsa Yoanna-Isul, 5th Multifunctional Hospital Core Study Team: 
Dr. Zaid Sabti Natascha Herr NEWSLETTER Dr. Dayana Flores Home News Team Studies Publications Events Cooperations Contact Dr. Nikola Kozhuharov